Hyaluronic acid receptor-mediated hydration enhancement

The term "Hyaluronic acid receptor-mediated hydration enhancement" refers to the increase in tissue and cellular hydration that occurs when hyaluronic acid (HA) molecules bind to and are internalized by specific cell surface receptors, notably CD44 and receptor for hyaluronan-mediated motility (RHAMM, CD168). These interactions are crucial for the maintenance of extracellular matrix hydration, cell motility, and tissue repair. HA is a high molecular weight glycosaminoglycan with a strong affinity for water, providing viscoelastic and lubricating properties in tissues like skin and joints. Through receptor-mediated uptake and signaling, HA influences cellular proliferation, inflammation, and tissue regeneration[1][3][6][7]. Although HA and its receptors are not a "single target" in the classical sense, both CD44 and RHAMM serve as bona fide receptors for HA and represent actual therapeutic targets or biomarkers in multiple disease contexts including inflammation, cancer, and skin aging[3][6]. For structured data and drug development, the true molecular targets involved in HA-mediated hydration enhancement are: CD44 (CD44 antigen, HA receptor) and Receptor for hyaluronan-mediated motility (RHAMM, CD168). In summary, "Hyaluronic acid receptor-mediated hydration enhancement" is not itself a specific molecule or therapeutic target, but a process involving multiple well-characterized HA receptors, especially CD44 and RHAMM[3][6].

Other names

HA receptor-mediated hydrationHyaluronan receptor-mediated hydrationHyaluronic acid uptake via receptors

Enhancement of tissue hydration via HA binding to cell surface receptors such as CD44 and RHAMM, leading to increased retention of water and modulation of cellular activities